Skip to main content
Erschienen in: Annals of Hematology 2/2015

01.02.2015 | Original Article

DNA topoisomerase IIβ as a molecular switch in neural differentiation of mesenchymal stem cells

verfasst von: Sevim Isik, Merve Zaim, Mehmet Taha Yildiz, Yesim Negis, Tuba Kunduraci, Nihal Karakas, Gulsum Arikan, Guven Cetin

Erschienen in: Annals of Hematology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Two isoforms of DNA topoisomerase II (topo II) have been identified in mammalian cells, named topo IIα and topo IIβ. Topo IIα plays an essential role in segregation of daughter chromosomes and thus for cell proliferation in mammalian cells. Unlike its isozyme topo IIα, topo IIβ is greatly expressed upon terminal differentiation of neuronal cells. Although there have been accumulating evidence about the crucial role of topo IIβ in neural development through activation or repression of developmentally regulated genes at late stages of neuronal differentiation, there have been no reports that analyzed the roles of topo IIβ in the neural trans differentiation process of multipotent stem cells. Terminal differentiation of neurons and transdifferentiation of Mesenchymal Stem Cells (MSCs) are two distinct processes. Therefore, the functional significance of topo IIβ may also be different in these differentiation systems. MSC transdifferentiation into neuron-like cells represents an useful model to further validate the role of topo IIβ in neuronal differentiation. The aim of this study is to evaluate the subset of genes that are regulated in neural transdifferentiation of bone marrow-derived human MSCs (BM-hMSCs) in vitro and find genes related with topo IIβ. For this purpose, topo IIβ was silenced by specific small interfering RNAs in hMSCs and cells were induced to differentiate into neuron-like cells. Differentiation and silencing of topo IIβ were monitored by real-time cell analysis and also expressions of topo II isoforms were analyzed. Change in transcription patterns of genes upon topo IIβ silencing was identified by DNA microarray analysis, and apparently genes involved in regulation of several ion channels and transporters, vesicle function, and cell calcium metabolism were particularly affected by topo IIβ silencing suggesting that topoIIβ silencing can significantly alter the gene expression pattern of genes involved in variety of biological processes and signal transduction pathways including transcription, translation, cell trafficking, vesicle function, transport, cell morphology, neuron guidance, growth, polarity, and axonal growth. It appears that the deregulation of these pathways may contribute to clarify the further role of topo IIβ in neural differentiation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bak M, Hansen C, Tommerup N, Larsen LA (2003) The Hedgehog signaling pathway—implications for drug targets in cancer and neurodegenerative disorders. Pharmacogenomics 4(4):411–429PubMedCrossRef Bak M, Hansen C, Tommerup N, Larsen LA (2003) The Hedgehog signaling pathway—implications for drug targets in cancer and neurodegenerative disorders. Pharmacogenomics 4(4):411–429PubMedCrossRef
2.
Zurück zum Zitat Barzilay R, Melamed E, Offen D (2009) Introducing transcription factors to multipotent mesenchymal stem cells: making trans differentiation possible. Stem Cells 27(10):2509–2515PubMedCrossRef Barzilay R, Melamed E, Offen D (2009) Introducing transcription factors to multipotent mesenchymal stem cells: making trans differentiation possible. Stem Cells 27(10):2509–2515PubMedCrossRef
3.
Zurück zum Zitat Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317PubMedCrossRef Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317PubMedCrossRef
4.
Zurück zum Zitat Edward H, Koo RK (2004) Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration. Nat Med 10:S26–S33CrossRef Edward H, Koo RK (2004) Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration. Nat Med 10:S26–S33CrossRef
5.
Zurück zum Zitat Ito D, Walker JR, Thompson CS, Moroz I, Lin W, Veselits ML, Hakim AM, Fienberg AA, Thinakaran G (2004) Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol Cell Biol 24(21):9456–9469PubMedCentralPubMedCrossRef Ito D, Walker JR, Thompson CS, Moroz I, Lin W, Veselits ML, Hakim AM, Fienberg AA, Thinakaran G (2004) Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol Cell Biol 24(21):9456–9469PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Ju BG, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, Glass CK, Rosenfeld MG (2006) A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science 312(5781):1798–1802PubMedCrossRef Ju BG, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, Glass CK, Rosenfeld MG (2006) A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science 312(5781):1798–1802PubMedCrossRef
7.
Zurück zum Zitat Kamaci N, Emnacar T, Karakas N, Arikan G, Tsutsui K, Isik S (2011) Selective silencing of DNA topoisomerase IIbeta in human mesenchymal stem cells by siRNAs (small interfering RNAs). Cell Biol Int Rep 18(1):e00010, 2010CrossRef Kamaci N, Emnacar T, Karakas N, Arikan G, Tsutsui K, Isik S (2011) Selective silencing of DNA topoisomerase IIbeta in human mesenchymal stem cells by siRNAs (small interfering RNAs). Cell Biol Int Rep 18(1):e00010, 2010CrossRef
8.
Zurück zum Zitat Kawano S, Miyaji M, Ichiyasu S, Tsutsui KM, Tsutsui K (2010) Regulation of DNA topoisomerase IIbeta through RNA-dependent association with heterogeneous nuclear ribonucleoprotein U (hnRNP U). J Biol Chem 285(34):26451–26460PubMedCentralPubMedCrossRef Kawano S, Miyaji M, Ichiyasu S, Tsutsui KM, Tsutsui K (2010) Regulation of DNA topoisomerase IIbeta through RNA-dependent association with heterogeneous nuclear ribonucleoprotein U (hnRNP U). J Biol Chem 285(34):26451–26460PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Kondapi AK, Mulpuri N, Mandraju RK, Sasikaran B, Subba Rao K (2004) Analysis of age dependent changes of topoisomerase II alpha and beta in rat brain. Int J Dev Neurosci 22(1):19–30PubMedCrossRef Kondapi AK, Mulpuri N, Mandraju RK, Sasikaran B, Subba Rao K (2004) Analysis of age dependent changes of topoisomerase II alpha and beta in rat brain. Int J Dev Neurosci 22(1):19–30PubMedCrossRef
10.
Zurück zum Zitat Kramer AH, Joos-Vandewalle J, Edkins AL, Frost CL, Prinsloo E (2014) Real-time monitoring of 3 T3-L1 preadipocyte differentiation using a commercially available electric cell-substrate impedance sensor system. Biochem Biophys Res Commun 443(4):1245–1250PubMedCrossRef Kramer AH, Joos-Vandewalle J, Edkins AL, Frost CL, Prinsloo E (2014) Real-time monitoring of 3 T3-L1 preadipocyte differentiation using a commercially available electric cell-substrate impedance sensor system. Biochem Biophys Res Commun 443(4):1245–1250PubMedCrossRef
11.
Zurück zum Zitat LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease. Nat Rev Neurosci 3(11):862–872PubMedCrossRef LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease. Nat Rev Neurosci 3(11):862–872PubMedCrossRef
12.
Zurück zum Zitat Lee HG, Casadesus G, Nunomura A, Zhu X, Castellani RJ, Richardson SL, Perry G, Felsher DW, Petersen RB, Smith MA (2009) The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol 174(3):891–897PubMedCentralPubMedCrossRef Lee HG, Casadesus G, Nunomura A, Zhu X, Castellani RJ, Richardson SL, Perry G, Felsher DW, Petersen RB, Smith MA (2009) The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol 174(3):891–897PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Lelièvre EC, Plestant C, Boscher C, Wolff E, Mège R-M, Birbes H (2012) N-Cadherin mediates neuronal cell survival through Bim down-regulation. PLoS ONE 7(3):e33206PubMedCentralPubMedCrossRef Lelièvre EC, Plestant C, Boscher C, Wolff E, Mège R-M, Birbes H (2012) N-Cadherin mediates neuronal cell survival through Bim down-regulation. PLoS ONE 7(3):e33206PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Long X, Olszewski M, Huang W, Kletzel M (2005) Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Dev 14(1):65–69PubMedCrossRef Long X, Olszewski M, Huang W, Kletzel M (2005) Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Dev 14(1):65–69PubMedCrossRef
15.
Zurück zum Zitat Lu P, Blesch A, Tuszynski MH (2004) Induction of bone marrow stromal cells to neurons: differentiation, trans differentiation, or artifact? J Neurosci Res 77(2):174–191PubMedCrossRef Lu P, Blesch A, Tuszynski MH (2004) Induction of bone marrow stromal cells to neurons: differentiation, trans differentiation, or artifact? J Neurosci Res 77(2):174–191PubMedCrossRef
16.
Zurück zum Zitat Lu P, Jones LL, Tuszynski MH (2005) BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol 191(2):344–360PubMedCrossRef Lu P, Jones LL, Tuszynski MH (2005) BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol 191(2):344–360PubMedCrossRef
17.
Zurück zum Zitat Lyu YL, Lin CP, Azarova AM, Cai L, Wang JC, Liu LF (2006) Role of topoisomerase IIbeta in the expression of developmentally regulated genes. Mol Cell Biol 26(21):7929–7941PubMedCentralPubMedCrossRef Lyu YL, Lin CP, Azarova AM, Cai L, Wang JC, Liu LF (2006) Role of topoisomerase IIbeta in the expression of developmentally regulated genes. Mol Cell Biol 26(21):7929–7941PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Lyu YL, Wang JC (2003) Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta. Proc Natl Acad Sci U S A 100(12):7123–7128PubMedCentralPubMedCrossRef Lyu YL, Wang JC (2003) Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta. Proc Natl Acad Sci U S A 100(12):7123–7128PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Mackenzie F, Ruhrberg C (2012) Diverse roles for VEGF-A in the nervous system. Development 139(8):1371–1380PubMedCrossRef Mackenzie F, Ruhrberg C (2012) Diverse roles for VEGF-A in the nervous system. Development 139(8):1371–1380PubMedCrossRef
20.
Zurück zum Zitat Nowacka MM, Obuchowicz E (2012) Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action. Neuropeptides 46(1):1–10PubMedCrossRef Nowacka MM, Obuchowicz E (2012) Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action. Neuropeptides 46(1):1–10PubMedCrossRef
21.
Zurück zum Zitat Nur EKA, Meiners S, Ahmed I, Azarova A, Lin CP, Lyu YL, Liu LF (2007) Role of DNA topoisomerase IIbeta in neurite outgrowth. Brain Res 1154:50–60CrossRef Nur EKA, Meiners S, Ahmed I, Azarova A, Lin CP, Lyu YL, Liu LF (2007) Role of DNA topoisomerase IIbeta in neurite outgrowth. Brain Res 1154:50–60CrossRef
22.
Zurück zum Zitat Reiner A, Albin RL, Anderson KD, D’Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci 85(15):5733–5737PubMedCentralPubMedCrossRef Reiner A, Albin RL, Anderson KD, D’Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci 85(15):5733–5737PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR, Sanberg PR (2000) Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164(2):247–256PubMedCrossRef Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR, Sanberg PR (2000) Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164(2):247–256PubMedCrossRef
25.
Zurück zum Zitat Sano K, Miyaji-Yamaguchi M, Tsutsui KM, Tsutsui K (2008) Topoisomerase IIbeta activates a subset of neuronal genes that are repressed in AT-rich genomic environment. PLoS One 3(12):e4103PubMedCentralPubMedCrossRef Sano K, Miyaji-Yamaguchi M, Tsutsui KM, Tsutsui K (2008) Topoisomerase IIbeta activates a subset of neuronal genes that are repressed in AT-rich genomic environment. PLoS One 3(12):e4103PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Thakurela S, Garding A, Jung J, Schubeler D, Burger L, Tiwari VK (2013) Gene regulation and priming by topoisomerase IIalpha in embryonic stem cells. Nat Commun 4:2478PubMedCrossRef Thakurela S, Garding A, Jung J, Schubeler D, Burger L, Tiwari VK (2013) Gene regulation and priming by topoisomerase IIalpha in embryonic stem cells. Nat Commun 4:2478PubMedCrossRef
27.
Zurück zum Zitat Tsutsui K, Tsutsui K, Hosoya O, Sano K, Tokunaga A (2001) Immunohistochemical analyses of DNA topoisomerase II isoforms in developing rat cerebellum. J Comp Neurol 431(2):228–239PubMedCrossRef Tsutsui K, Tsutsui K, Hosoya O, Sano K, Tokunaga A (2001) Immunohistochemical analyses of DNA topoisomerase II isoforms in developing rat cerebellum. J Comp Neurol 431(2):228–239PubMedCrossRef
28.
Zurück zum Zitat Tsutsui K, Tsutsui K, Sano K, Kikuchi A, Tokunaga A (2001) Involvement of DNA topoisomerase IIbeta in neuronal differentiation. J Biol Chem 276(8):5769–5778PubMedCrossRef Tsutsui K, Tsutsui K, Sano K, Kikuchi A, Tokunaga A (2001) Involvement of DNA topoisomerase IIbeta in neuronal differentiation. J Biol Chem 276(8):5769–5778PubMedCrossRef
29.
Zurück zum Zitat Wang JC (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 3(6):430–440PubMedCrossRef Wang JC (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 3(6):430–440PubMedCrossRef
30.
Zurück zum Zitat Watanabe M, Tsutsui K, Tsutsui K, Inoue Y (1994) Differential expressions of the topoisomerase II alpha and II beta mRNAs in developing rat brain. Neurosci Res 19(1):51–57PubMedCrossRef Watanabe M, Tsutsui K, Tsutsui K, Inoue Y (1994) Differential expressions of the topoisomerase II alpha and II beta mRNAs in developing rat brain. Neurosci Res 19(1):51–57PubMedCrossRef
31.
Zurück zum Zitat Woodbury D, Schwarz EJ, Prockop DJ, Black IB (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61(4):364–370PubMedCrossRef Woodbury D, Schwarz EJ, Prockop DJ, Black IB (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61(4):364–370PubMedCrossRef
32.
Zurück zum Zitat Yang X, Li W, Prescott ED, Burden SJ, Wang JC (2000) DNA topoisomerase IIbeta and neural development. Science 287(5450):131–134PubMedCrossRef Yang X, Li W, Prescott ED, Burden SJ, Wang JC (2000) DNA topoisomerase IIbeta and neural development. Science 287(5450):131–134PubMedCrossRef
Metadaten
Titel
DNA topoisomerase IIβ as a molecular switch in neural differentiation of mesenchymal stem cells
verfasst von
Sevim Isik
Merve Zaim
Mehmet Taha Yildiz
Yesim Negis
Tuba Kunduraci
Nihal Karakas
Gulsum Arikan
Guven Cetin
Publikationsdatum
01.02.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Annals of Hematology / Ausgabe 2/2015
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-014-2209-7

Weitere Artikel der Ausgabe 2/2015

Annals of Hematology 2/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.